Homozygous acute intermittent porphyria in a 7-year-old boy with massive excretions of porphyrins and porphyrin precursors
- PMID: 14970743
- DOI: 10.1023/B:BOLI.0000016613.75677.05
Homozygous acute intermittent porphyria in a 7-year-old boy with massive excretions of porphyrins and porphyrin precursors
Abstract
A 7-year-old boy demonstrating hepatosplenomegaly, mild anaemia, mild mental retardation, yellow-brown teeth and dark red urine had excessively elevated levels of urinary delta-aminolevulinic acid, porphobilinogen and uroporphyrin. Furthermore hepta-, hexa-, penta- and copro(I)porphyrins were highly increased in urine. This pattern of porphyrin precursor and metabolite excretion is characteristic of acute intermittent porphyria. The decreased copro(III)/copro(I+III) ratio, normally not found in acute intermittent porphyria, is discussed. The porphobilinogen deaminase activity in red cells was decreased to 2-4%. Mutation analysis revealed a novel homozygous L81P mutation in exon 6 of the porphobilinogen deaminase gene. The father and mother, shown to be gene carriers of the same mutation, are asymptomatic and have normal urinary porphyrin precursor and metabolite excretion.
Similar articles
-
Heterogeneity of acute intermittent porphyria: a subtype with normal erythrocyte porphobilinogen deaminase activity in Germany.Eur J Clin Chem Clin Biochem. 1996 Aug;34(8):613-8. doi: 10.1515/cclm.1996.34.8.613. Eur J Clin Chem Clin Biochem. 1996. PMID: 8877336
-
Safety, pharmacokinetics and pharmocodynamics of recombinant human porphobilinogen deaminase in healthy subjects and asymptomatic carriers of the acute intermittent porphyria gene who have increased porphyrin precursor excretion.Clin Pharmacokinet. 2007;46(4):335-49. doi: 10.2165/00003088-200746040-00006. Clin Pharmacokinet. 2007. PMID: 17375984 Clinical Trial.
-
Interdependence between degree of porphyrin excess and disease severity in congenital erythropoietic porphyria (Günther's disease).Arch Dermatol Res. 1997 Apr;289(5):272-6. doi: 10.1007/s004030050192. Arch Dermatol Res. 1997. PMID: 9164637
-
Molecular basis of acute intermittent porphyria.Mol Med Today. 1995 Aug;1(5):232-9. doi: 10.1016/s1357-4310(95)91513-3. Mol Med Today. 1995. PMID: 17607885 Review.
-
The three-dimensional structures of mutants of porphobilinogen deaminase: toward an understanding of the structural basis of acute intermittent porphyria.Protein Sci. 1994 Oct;3(10):1644-50. doi: 10.1002/pro.5560031004. Protein Sci. 1994. PMID: 7849582 Free PMC article. Review.
Cited by
-
The acute hepatic porphyrias.Transl Gastroenterol Hepatol. 2021 Apr 5;6:24. doi: 10.21037/tgh-2020-01. eCollection 2021. Transl Gastroenterol Hepatol. 2021. PMID: 33824928 Free PMC article. Review.
-
Recent advances on porphyria genetics: Inheritance, penetrance & molecular heterogeneity, including new modifying/causative genes.Mol Genet Metab. 2019 Nov;128(3):320-331. doi: 10.1016/j.ymgme.2018.11.012. Epub 2018 Nov 30. Mol Genet Metab. 2019. PMID: 30594473 Free PMC article. Review.
-
Biochemical compared to molecular diagnosis in acute intermittent porphyria.J Inherit Metab Dis. 2006 Feb;29(1):157-61. doi: 10.1007/s10545-006-0155-9. J Inherit Metab Dis. 2006. PMID: 16601882
-
HMBS gene mutations and hydroxymethylbilane synthase activity in acute intermittent porphyria: A systematic review.Medicine (Baltimore). 2023 Sep 29;102(39):e35144. doi: 10.1097/MD.0000000000035144. Medicine (Baltimore). 2023. PMID: 37773850 Free PMC article.
-
Feline acute intermittent porphyria: a phenocopy masquerading as an erythropoietic porphyria due to dominant and recessive hydroxymethylbilane synthase mutations.Hum Mol Genet. 2010 Feb 15;19(4):584-96. doi: 10.1093/hmg/ddp525. Epub 2009 Nov 24. Hum Mol Genet. 2010. PMID: 19934113 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases